Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia

PLoS Medicine

Volumn 4, Issue 2, 2007, Pages 0280-0287

  Shargie, Estifanos Biru ^a,b   Lindtjørn, Bernt ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b Southern Nations   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; CONTROLLED STUDY; ETHIOPIA; FOLLOW UP; HUMAN; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; SPUTUM SMEAR; STRUCTURED QUESTIONNAIRE; ADOLESCENT; ADULT; CLINICAL TRIAL; FEMALE; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROSPECTIVE STUDY; STATISTICS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; ETHIOPIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PREVALENCE; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 33847613372     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040037     Document Type: Article

References (30)

1. Mitchison DA (1998) How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 2: 10-15.
2. Zellweger JP, Coulon P (1998) Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 2: 372-377.
3. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, et al. (1997) Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 111: 1168-1173.
4. Thomas C (2002) A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy. J Manag Med 16: 371-400.
5. Kassim S, Sassam-Morokro M, Akhan A, Abouya LY, Digbeu H, et al. (1995) Two-year follow-up of persons with HIV-1 and HIV-2-associated pulmonary tuberculosis treated with short-course in West Africa. AIDS 9: 1185-1191.
6. Kazeonny B, Khorosheva T, Aptekar T, Rybka L, Kluge H, et al. (2001) Evaluation of directly observed therapy short course strategy for treating tuberculosis-Orel Oblast, Russian Federation, 1999-2000. MMWR 50: 204-206.
7. Zhang L-X, Tu DH, Enarson DA (2000) The impact of directly observed treatment on the epidemiology of tuberculosis in Beijing. Int J Tuberc Lung Dis 4: 904-910.
8. Volmink J, Garner P (2001) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 4: CD003343.
9. Wally JD, Khan MA, Newell JN, Khan MH (2001) Effectiveness of the direct observation component of DOTS for tuberculosis: A randomised controlled trial in Pakistan. Lancet 357: 664-669.
10. Squire SB, Wilkinson D (1997) Strengthening "DOTS" through community care for tuberculosis. BMJ 315: 1395-1396.
11. Volmink J, Garner P (1997) Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 315: 1403-1406.
12. Volmink J, Garner P (2000) Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 4: CD000010.
13. Sanou A, Dembele M, Theobald S, Macq J (2004) Access and adhering to tuberculosis treatment: Barriers faced by patients and communities in Burkina Faso. Int J Tuberc Lung Dis. 8: 1479-1483.
14. Jaiswal A, Singh V, Ogden JA, Porter JD, Sharma PP, et al. (2003) Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India. Trop Med Int Health 8: 625-633.
15. World Health Organization (2005) Global tuberculosis control: Surveillance, planning, financing. WHO Report 2005. Publication WHO/HTM/TB/2005.349. Geneva: World Health Organization. 258 p.
16. Demissie M, Kebede D (1994) Defaulting from tuberculosis treatment at the Addis Ababa Tuberculosis Centre and factors associated with it. Ethiop Med J 32: 97-106.
17. Tekle B, Mariam DH, Ali A (2002) Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 6: 573-579.
18. Shargie EB, Lindtjorn B (2005) DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: A retrospective trend analysis. BMC Public Health 5: 62.
19. Ministry of Health of Ethiopia (2002) Tuberculosis and leprosy control programme manual. 2nd edition. Addis Ababa: Ministry of Health of Ethiopia. 122 p.
20. Nuwaha F (1997) Factors influencing completion of treatment among tuberculosis patients in Mbarara District, Uganda. East Afr Med J 74: 690-693.
21. Kaona FA, Tuba M, Siziya S, Sikaona L (2004) An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 4: 68.
22. Nuwaha F (1999) Control of tuberculosis in Uganda: A tale of two districts. Int J Tuberc Lung Dis 3: 224-230.
23. Comolet TM, Rakotomalala R, Rajaonarioa H (1998) Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis 2: 891-897.
24. Salles CL, Conde MB, Hofer C, Cunha AJ, Calcada AL, et al. (2004) Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 8: 318-322.
25. Chang KC, Leung CC, Tam CM (2004) Risk factors for defaulting from antituberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 8: 1492-1498.
26. Southern Nations Nationalities and Peoples' Regional State Health Bureau (2003) The health sector development plan: PhaseII (2003-2005). Awassa, Ethiopia: Southern Nations Nationalities and Peoples' Regional State Health Bureau. 139 p.
27. Getahun H, Maher D (2000) Contribution of "TB clubs" to tuberculosis control in a rural district in Ethiopia. Int J Tuberc Lung Dis 4: 174-178.
28. Demissie M, Getahun H, Lindtjorn B (2003) Community tuberculosis care through "TB clubs" in rural North Ethiopia. Soc Sci Med 56: 2009-2018.
29. Federal Ministry of Health (2005) Health sector strategic plan: HSDP-III (2006-2010). Addis Ababa: Planning and Programming Department, Federal Ministry of Health. 143 p.
30. Jinadani A, Nunn AJ, Enarson DA (2004) Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: International multicentre randomised trial. Lancet 364: 1244-1251.